Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, May 2, 2023
[ Tue, May 02nd 2023
] - WOPRAI
[ Tue, May 02nd 2023
] - WOPRAI
[ Tue, May 02nd 2023
] - WOPRAI
[ Tue, May 02nd 2023
] - WOPRAI
[ Tue, May 02nd 2023
] - WOPRAI
[ Tue, May 02nd 2023
] - WOPRAI
[ Tue, May 02nd 2023
] - WOPRAI
[ Tue, May 02nd 2023
] - WOPRAI
[ Tue, May 02nd 2023
] - WOPRAI
[ Tue, May 02nd 2023
] - WOPRAI
[ Tue, May 02nd 2023
] - WOPRAI
[ Tue, May 02nd 2023
] - WOPRAI
[ Tue, May 02nd 2023
] - WOPRAI
[ Tue, May 02nd 2023
] - WOPRAI
[ Tue, May 02nd 2023
] - WOPRAI
[ Tue, May 02nd 2023
] - WOPRAI
[ Tue, May 02nd 2023
] - WOPRAI
[ Tue, May 02nd 2023
] - WOPRAI
[ Tue, May 02nd 2023
] - WOPRAI
[ Tue, May 02nd 2023
] - WOPRAI
[ Tue, May 02nd 2023
] - WOPRAI
[ Tue, May 02nd 2023
] - WOPRAI
[ Tue, May 02nd 2023
] - WOPRAI
[ Tue, May 02nd 2023
] - WOPRAI
[ Tue, May 02nd 2023
] - WOPRAI
[ Tue, May 02nd 2023
] - WOPRAI
[ Tue, May 02nd 2023
] - WOPRAI
[ Tue, May 02nd 2023
] - WOPRAI
[ Tue, May 02nd 2023
] - WOPRAI
[ Tue, May 02nd 2023
] - WOPRAI
Francois Brisebois Maintained (AVDL) at Buy with Increased Target to $22 on, May 2nd, 2023
Francois Brisebois of Oppenheimer, Maintained "Avadel Pharmaceuticals plc" (AVDL) at Buy with Increased Target from $20 to $22 on, May 2nd, 2023.
Francois, nor any peers, have made any analyst calls on AVDL in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30